Altered expression of circadian clock genes in human chronic myeloid leukemia

Journal of Biological Rhythms

Volumn 26, Issue 2, 2011, Pages 136-148

  Yang, Ming Yu ^a,b   Yang, Wen Chi ^b   Lin, Pai Mei ^c   Hsu, Jui Feng ^b   Hsiao, Hui Hua ^b,d   Liu, Yi Chang ^b,d   Tsai, Hui Jen ^b,d   Chang, Chao Sung ^b,d   Lin, Sheng Fung ^b,d  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

chronic myeloid leukemia (CML); circadian clock genes; circadian rhythm; complete cytogenetic response (CCyR); imatinib mesylate; major molecular response (MMR)

Indexed keywords

NUCLEAR PROTEIN;

ADULT; ARTICLE; BIOSYNTHESIS; BLOOD; CHRONIC MYELOID LEUKEMIA; CIRCADIAN RHYTHM; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MONONUCLEAR CELL; NEUTROPHIL; PHYSIOLOGY;

ADULT; CIRCADIAN CLOCKS; CIRCADIAN RHYTHM; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKOCYTES, MONONUCLEAR; MALE; NEUTROPHILS; NUCLEAR PROTEINS;

EID: 79953270824     PISSN: 07487304     EISSN: 15524531     Source Type: Journal    
DOI: 10.1177/0748730410395527     Document Type: Article

References (55)

1. Apperley JF, Gardembas M., Melo JV, Russell-Jones R., Bain BJ, Baxter EJ, Chase A., Chessells JM, Colombat M., Dearden CE, et al (2002) Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta. N Engl J Med 347: 481-487. (Pubitemid 34879335)
2. Archer SN, Viola AU, Kyriakopoulou V., von Schantz M., and Dijk DJ (2008) Inter-individual differences in habitual sleep timing and entrained phase of endogenous circadian rhythms of BMAL1, PER2 and PER3 mRNA in human leukocytes. Sleep 31: 608-617. (Pubitemid 351694249)
3. Baccarani M., Cortes J., Pane F., Niederwieser D., Saglio G., Apperley J., Cervantes F., Deininger M., Gratwohl A., Guilhot F., et al. European LeukemiaNet (2009) Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet. J Clin Oncol 27: 6041-6051.
4. Baccarani M. and Dreyling M. ; ESMO Guidelines Working Group (2009) Chronic myelogenous leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol Suppl 4: 105-107.
5. Balsalobre A. (2002) Clock genes in mammalian peripheral tissues. Cell Tissue Res 309: 193-199. (Pubitemid 34744041)
6. Bjarnason GA and Jordan R. (2000) Circadian variation of cell proliferation and cell cycle protein expression in man: clinical implications. Prog Cell Cycle Res 4: 193-206.
7. Bjarnason GA, Jordan RC, Wood PA, Li Q., Lincoln DW, Sothern RB, Hrushesky WJ, and Ben-David Y. (2001) Circadian expression of clock genes in human oral mucosa and skin: association with specific cell-cycle phases. Am J Pathol 158: 1793-1801. (Pubitemid 32422944)
8. Boivin DB, James FO, Wu A., Cho-Park PF, Xiong H., and Sun ZS (2003) Circadian clock genes oscillate in human peripheral blood mononuclear cells. Blood 102: 4143-4145. (Pubitemid 37487000)
9. Chen ST, Choo KB, Hou MF, Yeh KT, Kuo SJ, and Chang JG (2005) Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26: 1241-1246.
10. Davis S., Mirick DK, and Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93: 1557-1562. (Pubitemid 32998485)
11. Druker BJ, Guilhot F., O'Brien SG, Gathmann I., Kantarjian H., Gattermann N., Deininger MW, Silver RT, Goldman JM, Stone RM, et al. IRIS Investigators (2006) Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 355: 2408-2417. (Pubitemid 44903745)
12. Eisele L., Prinz R., Klein-Hitpass L., Nückel H., Lowinski K., Thomale J., Moeller LC, Dührsen U., and Dürig J. (2009) Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia. Eur J Haematol 83: 320-327.
13. Filipski E., King VM, Li X., Granda TG, Mormont MC, Liu X., Claustrat B., Hastings MH, and Lévi F. (2002) Host circadian clock as a control point in tumor progression. J Natl Cancer Inst 94: 690-697. (Pubitemid 34552490)
14. Fu L. and Lee CC (2003) The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer 3: 350-361. (Pubitemid 37328855)
15. Fukuya H., Emoto N., Nonaka H., Yagita K., Okamura H., and Yokoyama M. (2007) Circadian expression of clock genes in human peripheral leukocytes. Biochem Biophy Res Comm 354: 924-928. (Pubitemid 46216221)
16. Gery S., Komatsu N., Kawamata N., Miller CW, Desmond J., Virk RK, Marchevsky A., Mckenna R., Taguchi H., and Koeffler HP (2007) Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer. Clin Cancer Res 13: 1399-1404. (Pubitemid 46450428)
17. Granda TG and Lévi F. (2002) Tumor-based rhythms of anticancer efficacy in experimental models. Chronobiol Int 19: 21-41. (Pubitemid 34310818)
18. Hastings MH, Reddy AB, and Maywood ES (2003) A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 4: 649-661. (Pubitemid 37280160)
19. Herichová I., Mravec B., Stebelová K., Krizanová O., Jurkovicová D., Kvetnanský R., and Zeman M. (2007) Rhythmic clock gene expression in heart, kidney and some brain nuclei involved in blood pressure control in hypertensive TGR(mREN-2)27 rats. Mol Cell Biochem 296: 25-34.
20. Hida K., Kusanagi H., Satoh K., Kato T., Matsumoto Y., Echizenya M., Shimizu T., Higuchi S., and Mishima K. (2009) Expression profiles of PERIOD1, 2, and 3 in peripheral blood mononuclear cells from older subjects. Life Sci 84: 3-7.
21. Hrushesky WJM, Lannin D., and Haus E. (1998) Evidence from an ontogenetic basis for circadian coordination of cancer proliferation. J Natl Cancer Inst 90: 1480-1484. (Pubitemid 28482013)
22. Hsu MC, Huang CC, Choo KB, and Huang CJ (2007) Uncoupling of promoter methylation and expression of Period1 in cervical cancer cells. Biochem Biophys Res Commun 360: 257-262.
23. Hughes T., Deininger M., Hochhaus A., Branford S., Radich J., Kaeda J., Baccarani M., Cortes J., Cross NC, Druker BJ, et al (2006) Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. Blood 108: 28-37. (Pubitemid 43990609)
24. Innominato PF, Focan C., Gorlia T., Moreau T., Garufi C., Waterhouse J., Giacchetti S., Coudert B., Iacobelli S., Genet D., et al. Chronotherapy Group of the European Organization for Research and Treatment of Cancer (2009) Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res 69: 4700-4707.
25. Joensuu H., Roberts PJ, Sarlomo-Rikala M., Andersson LC, Tervahartiala P., Tuveson D., Silberman S., Capdeville R., Dimitrijevic S., Druker B., et al (2001) Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 344: 1052-1056. (Pubitemid 32267975)
26. Kantarjian HM, Dixon D., Keating MJ, Talpaz M., Walters RS, McCredie KB, and Freireich EJ (1988) Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer 61: 1441-1446. (Pubitemid 18076421)
27. Krugluger W., Brandstaetter A., Kállay E., Schueller J., Krexner E., Kriwanek S., Bonner E., and Cross HS (2007) Regulation of genes of the circadian clock in human colon cancer: reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res 67: 7917-7922. (Pubitemid 47281388)
28. Kusanagi H., Mishima K., Satoh K., Echizenya M., Katoh T., and Shimizu T. (2004) Similar profiles in human period1 gene expression in peripheral mononuclear and polymorphonuclear cells. Neurosci Lett 365: 124-127. (Pubitemid 38881638)
29. Kusanagi H., Hida A., Satoh K., Echizenya M., Shimizu T., Pendergast JS, Yamazaki S., and Mishima K. (2008) Expression profiles of 10 circadian clock genes in human peripheral blood mononuclear cells. Neurosci Res 61: 136-142.
30. Lee CC (2006) Tumor suppression by the mammalian Period genes. Cancer Causes Control 17: 525-530.
31. Lewintre EJ, Martin CR, Ballesteros CG, Montaner D., Rivera RF, Mayans JR, and Garcia-Conde (2008) Cryptochrome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia. Hematologica 94: 280-284.
32. Matsuo T., Yamaguchi S., Mitsui S., Emi A., Shimoda F., and Okamura H. (2003) Control mechanism of the circadian clock for timing of cell division in vivo. Science 302: 255-259. (Pubitemid 37248750)
33. Mormont MC, Waterhouse J., Bleuzen P., Giacchetti S., Jami A., Bogdan A., Lellouch J., Misset JL, Touitou Y. and Lévi F. (2000) Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6: 3038-3045. (Pubitemid 30637726)
34. Murga PEM, Cools J., Algenstaedt P., Hinz K., Seeger D., Schafhausen P., Schilling G., Marynen P., Hossfeld DK, and Dierlamm J. (2003) A novel cryptic translocation t(12;17)(p13;p12-p13) in a secondary acute myeloid leukemia results in a fusion of the ETV6 gene and the antisense strand of the PER1 gene. Genes Chromosomes Cancer 37: 79-83. (Pubitemid 36417924)
35. Park K. and Kang HM (2006) Circadian expression of clock genes in the rat eye and brain. Mol Cells 31: 285-290. (Pubitemid 46062292)
36. Reppert SM and Weaver DR (2001) Molecular analysis of mammalian circadian rhythms. Ann Rev Physiol 63: 647-678.
37. Reppert SM and Weaver DR (2002) Coordination of circadian timing in mammals. Nature 418: 935-941. (Pubitemid 34976023)
38. Sawyers CL (1999) Chronic myeloid leukemia. N Engl J Med 340: 1330-1340. (Pubitemid 29196596)
39. Schernhammer ES, Laden F., Speizer FE, Willett WC, Hunter DJ, Kawachi I., Fuchs CS, and Colditz GA (2003) Night-shift work and risk of colorectal cancer in the nurses' health study. J Natl Cancer Inst 95: 825-828. (Pubitemid 36798430)
40. Schernhammer ES, Laden F., Speizer FE, Willett WC, Hunter DJ, Kawachi I., and Colditz GA (2003) Rotating night shifts and risk of breast cancer in women participating in the nurses' health study. J Natl Cancer Inst 93: 1563-1568.
41. Schindler T., Bornmann W., Pellicena P., Miller WT, Clarkson B., and Kuriyan J. (2000) Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289: 1938-1942.
42. Shearman LP, Jin X., Lee C., Reppert SM, and Weaver DR (2000) Targeted disruption of the mPer3 gene: subtle effects on circadian clock function. Mol Cell Biol 20: 6269-6275. (Pubitemid 30650213)
43. Shih HC, Choo KB, Chang TJ, Yang MY, Shih MC, Yeh KT, Liu TC, Lin SF, and Chang JG (2005) Disturbance of circadian gene expression in endometrial cancer: detection by real-time quantitative RT-PCR. Oncol Rep 14: 1533-1538.
44. Shtivelman E., Lifshitz B., Gale RP, and Canaani E. (1985) Fused transcript of abl and bcr genes in chronic myelogenous leukaemia. Nature 315: 550-554. (Pubitemid 15021190)
45. Stevens RG (2005) Circadian disruption and breast cancer from melatonin to clock genes. Epidemiology 16: 254-258. (Pubitemid 40314419)
46. Strayer CA and Kay SA (1999) The ins and outs of circadian regulated gene expression. Curr Opin Plant Biol 2: 114-120. (Pubitemid 29181912)
47. Takata M., Burioka N., Ohdo S., Takane H., Terazono H., Miyata M., Sako T., Suyama H., Fukuoka Y., Tomita K., et al (2002) Daily expression of mRNAs for the mammalian Clock genes Per2 and clock in mouse suprachiasmatic nuclei and liver and human peripheral blood mononuclear cells. Jpn J Pharmacol 90: 263-269. (Pubitemid 35422944)
48. Talpaz M., Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C., Guilhot F., Schiffer CA, Fischer T., Deininger MW, Lennard AL, et al (2002) Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood 99: 1928-1937. (Pubitemid 34525471)
49. Teboul M., Barrat-Petit MA, Li XM, Claustrat B., Formento JL, Delaunay F., Lévi F., and Milano G. (2005) Atypical patterns of circadian clock gene expression in human peripheral blood mononuclear cells. J Mol Med 83: 693-699. (Pubitemid 41225111)
50. Tsinkalovsky O., Smaaland R., Rosenlund B., Sothern RB, Hirt A., Steine S., Badiee A., Abrahamsen JF, Eiken HG and Laerum OD (2007) Circadian variations in clock gene expression of human bone marrow CD34+ cells. J Biol Rhythms 22: 140-150. (Pubitemid 46568652)
51. Weaver DR (1998) The suprachiasmatic nucleus: a 25-year retrospective. J Biol Rhythms 13: 100-112. (Pubitemid 128478927)
52. Winter SL, Bosnoyan-Collins L., Pinnaduwage D., and Andrulis IL (2007) Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia 9: 797-800. (Pubitemid 47623419)
53. Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HY, Liu TC, Hsiao HH, Liu YC, and Lin SF (2006) Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci 97: 1298-1307. (Pubitemid 44614980)
54. Young MW and Kay SA (2001) Time zones: a comparative genetics of circadian clocks. Nat Rev Genet 2: 702-715. (Pubitemid 33674792)
55. Zhu Y., Zheng T., Stevens RG, Zhang Y., and Boyle P. (2006) Does "Clock" matter in prostate cancer ? Cancer Epidemiol Biomarkers Prev 15: 3-5.